Napoli 3–3 AS Roma: match recap

Match recap

A six-goal thriller at the Stadio Maradona saw Napoli and AS Roma trade blows in a 3-3 draw, with Roma dominating shot volume (24-15) and Napoli maximizing their limited chances with clinical finishing. The match swung wildly, featuring a pair of braces and a super-sub who changed the game's complexion.

Napoli struck first through McTominay, who clinically dispatched two of his three shots on target in the first half, but Roma's relentless pressure — out-shooting the hosts 24-15 — kept them in the contest. De Bruyne's midfield industry (7 duels won, 2 interceptions) couldn't prevent Roma from generating chances, and after the break, substitute Balerdi (2 goals in 32 minutes) turned the match on its head. Zambo Anguissa's goal (1 shot, 1 on target) kept Napoli level, but Soulé's goal and a further Balerdi strike put Roma ahead before a late equalizer. Despite Roma's 580 passes to Napoli's 378, the home side's shot accuracy (9 on target vs 4) proved decisive in salvaging a point.

Key factors

• The numbers tell the story here: see the key factors, team form and season numbers for what the statistics indicate.
• Roma's shot volume dominance: 24 total shots (9 more than Napoli), but only 4 on target, highlighting finishing inefficiency that cost them a potential win.
• Substitute impact: Balerdi's 2 goals in 32 minutes off the bench was the single most influential cameo, flipping Roma from trailing to leading.

The Analyst's take

Roma's 24 shots and 580 passes reflect a team that controlled the game's flow, but their 4 shots on target — just 17% accuracy — is a glaring inefficiency that must improve to turn dominance into wins. Napoli, despite being outplayed for long stretches, demonstrated lethal finishing (9 of 15 shots on target) and resilience, but their lack of possession (378 passes) and defensive frailty against Roma's volume will be a concern. Going forward, Roma's attacking depth (Balerdi as a super-sub) is a major asset, while Napoli need to tighten up without sacrificing their clinical advantage.